Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents mixed signals. While there is optimism about M&A activity and a forward dividend strategy, challenges such as AI risks, medical roll-up issues, and increased nonaccruals temper the outlook. The Q&A reveals ongoing concerns about asset performance and management's unclear responses on stock repurchases. The positive aspects like dividend strategy and M&A growth are offset by operational challenges and unclear guidance, suggesting a neutral stock price reaction.
Net Investment Income (NII) $0.48 per share, adjusted NII of $0.52 per share. This is compared to public guidance of $0.51 and $0.56 per share, respectively. The decline is attributed to investments placed on nonaccrual, lower base rates, and repayment of higher-yielding investments.
Net Asset Value (NAV) Declined by 5% to $20.89 per share from $21.99 per share at the end of the third quarter. The decline is due to a $0.22 per share impact from distributions exceeding GAAP NII and a $0.87 per share decline from downward pressure on certain investments.
Available Liquidity Approximately $3.8 billion at the end of the quarter. This reflects the company's strong liquidity position.
Total Investment Income $348 million for the fourth quarter, a decrease of $25 million compared to the third quarter. The decline is driven by lower interest income due to nonaccrual investments, lower base rates, and repayment of higher-yielding investments.
Weighted Average Yield on Accruing Debt Investments 10% as of December 31, a decrease of 50 basis points from 10.5% as of September 30. The decline is attributed to adjustments excluding accretion associated with the merger of FSKR.
Nonaccrual Assets Increased to 5.5% of the portfolio on a cost basis and 3.4% on a fair value basis as of December 31, compared to 5% and 2.9%, respectively, as of September 30. The increase is due to challenges in specific investments such as Medallia, Cubic Corp, and others.
New Investments Originated $1.1 billion during the fourth quarter, with 65% in first lien loans, 15% in asset-based finance investments, and 18% in capital calls to the joint venture. This reflects a focus on first lien loans and asset-based finance investments for better risk-adjusted returns.
Portfolio Metrics Weighted average EBITDA of portfolio companies was $236 million, with a median EBITDA of $132 million. Portfolio companies reported a weighted average year-over-year EBITDA growth rate of approximately 4%.
Dividend and Fee Income $92 million for the quarter, an increase of $4 million compared to the third quarter. This includes $58 million from the joint venture and $28 million from various portfolio companies.
Interest Expense $110 million for the quarter, a decrease of $6 million compared to the third quarter. The weighted average cost of debt was 5.1% as of December 31.
Origination of Investments: FSK originated $5.6 billion of predominantly first lien and asset-based finance investments in 2025.
New Middle Market CLOs: Issued $400 million of new unsecured notes and closed on a $400 million bilateral lending facility, diversifying funding sources through 2 new middle market CLOs.
Investment Opportunities: Experienced a 13% increase in the number of investment opportunities evaluated in 2025.
Portfolio Diversification: Focused on diversifying the portfolio by taking smaller position sizes in a greater number of borrowers.
Liquidity: Ended the quarter with approximately $3.8 billion of available liquidity.
Dividend Framework: Declared a total first quarter distribution of $0.48 per share, representing a 9.2% yield on the ending fourth quarter net asset value.
Portfolio Monitoring: Plans to address underperforming assets through restructurings, exits, and proactive monitoring to reduce nonaccruals and non-income-producing investments.
Focus on First Lien Senior Secured Originations: Continuing strategy to increase the quality and diversification of the investment portfolio.
Downward pressure on specific investments: During the second and fourth quarters of 2025, the company experienced downward pressure on a few specific investments, leading to a decline in net asset value. This includes challenges in legacy investments and current adviser-originated investments such as Medallia, Cubic Corp, KBS, and 48forty.
Nonaccrual assets: The company acknowledged that nonaccrual assets are higher than desired, which tempers near- to intermediate-term net investment income. Nonaccruals represented 5.5% of the portfolio on a cost basis and 3.4% on a fair value basis as of December 31, 2025.
Portfolio volatility: The company anticipates an above-average level of portfolio volatility during certain periods, coupled with lower levels of net investment income compared to prior estimates.
Specific investment losses: Significant losses were incurred from investments in Production Resource Group, Medallia, Peraton, and Cubic Corp, contributing to net realized and unrealized losses during the fourth quarter of 2025.
Competitive pressures: Medallia, an enterprise software platform, faced competitive pressures, resulting in financial underperformance and unrealized losses.
Order and implementation delays: Cubic Corp experienced order and implementation delays, leading to unrealized depreciation.
Softer operating performance: Production Resource Group faced softer operating performance due to headwinds in TV, film, and music segments, resulting in significant losses.
AI risks: Potential future risks from AI adoption were noted, which could negatively impact companies that have not achieved meaningful positive cash flows or are less well-positioned from a customer retention standpoint.
Decline in interest income: Interest income declined due to investments placed on nonaccrual, lower base rates, and the repayment of higher-yielding investments.
Elevated leverage levels: Gross and net debt-to-equity levels increased to 130% and 122%, respectively, as of December 31, 2025, which could pose risks to financial stability.
2026 Dividend Outlook: The 2026 dividend, initially projected to equate to approximately 10% of net asset value, is now expected to be around 9% of net asset value due to higher nonaccrual assets.
Portfolio Management Goals: The company plans to address underperforming assets through restructurings, exits, and proactive portfolio monitoring to reduce nonaccruals and non-income-producing investments.
Investment Strategy: FSK will continue focusing on first lien senior secured originations to enhance portfolio quality and diversification while rotating a portion of legacy investments.
Liquidity and Leverage: The company aims to preserve strong liquidity and balance sheet flexibility by maintaining net leverage within the target range and ensuring ample revolver capacity to manage volatility and selectively deploy capital.
First Quarter 2026 Financial Guidance: GAAP net investment income is expected to approximate $0.45 per share, and adjusted net investment income is expected to approximate $0.44 per share. Recurring interest income is projected at $226 million, with recurring dividend income from the joint venture at $60 million.
Capital Structure and Financing: The company closed its third middle market CLO, raising $363 million of low-cost secured debt at a weighted average rate of SOFR plus 157 basis points. Pro forma adjustments for bond maturities indicate a strong balance sheet with no significant maturities until January 2027.
Total Distributions in 2025: $2.80 per share through quarterly base and supplemental distributions.
First Quarter 2026 Distribution: $0.48 per share, consisting of $0.45 base distribution and $0.03 supplemental distribution.
Dividend Yield: 9.2% yield on ending fourth quarter net asset value.
2026 Dividend Expectation: Expected to be approximately 9% of net asset value, reduced from the original estimate of 10%.
Share Repurchase Program: No mention of a share repurchase program in the transcript.
The earnings call presents mixed signals. While there is optimism about M&A activity and a forward dividend strategy, challenges such as AI risks, medical roll-up issues, and increased nonaccruals temper the outlook. The Q&A reveals ongoing concerns about asset performance and management's unclear responses on stock repurchases. The positive aspects like dividend strategy and M&A growth are offset by operational challenges and unclear guidance, suggesting a neutral stock price reaction.
The earnings call summary and Q&A session present a mixed picture. While there are positive aspects such as the strategic planning for dividends, active share buybacks, and a strong base distribution level, there are also concerns about unclear guidance, potential tariff impacts, and limited details on restructuring and market spreads. The company's cautious outlook on M&A activity and fee income, along with management's avoidance of direct answers to certain questions, suggest a neutral sentiment overall. The lack of market cap data prevents a more precise prediction of stock price movement.
The earnings call summary provides a mixed picture. Strong financial metrics are offset by concerns about higher rate environments and government contracts. While there is optimism about consumer performance and new investments, the Q&A reveals issues with dividend guidance and asset re-defaults. The management's unclear responses to some questions add to uncertainties. The overall sentiment is neutral, reflecting balanced positive and negative factors.
The earnings call summary presents mixed signals: improvements in credit quality and shareholder distributions are positive, but decreased total investment income and net asset value are concerning. The Q&A reveals uncertainties, such as potential yield compression and recession risks. Despite some positive trends, the overall sentiment is cautious, with management avoiding direct answers on key issues. The lack of strong catalysts like new partnerships or optimistic guidance, combined with stable but unimpressive financial metrics, suggests a neutral impact on the stock price over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.